Secondary outcomes: ICU (3 trials) and hospital (5 trials) mortality, length of ICU stay (6 trials), duration of MV (5 trials)
- The number of patients studied in trials is small & 95% CIs encompass effects that are both clinically important & biologically plausible
- It is interesting to see that that such entrenched clinical practice is supported by such a poor evidence base